IP Library Granted Patent US 10,245,107
Granted Patent B2
US 10,245,107 · App. 14/340,961 · Granted Apr 2, 2019

Picosecond optical radiation systems and methods of use

Inventors: Rafael Armando Sierra (Palmer, MA); Mirko Georgiev Mirkov (Chelmsford, MA)
Assignee: CYNOSURE, INC.
A61B18/203A61N5/0616H01S3/0627H01S3/08018H01S3/094076H01S3/1024H01S3/1106H01S3/1109H01S3/1121A61B2018/0047A61N2005/067H01S3/0092H01S3/08054H01S3/093H01S3/094038H01S3/094084H01S3/107H01S3/1611H01S3/1623H01S3/1633H01S3/1643H01S3/1673
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,245,107
App. No.
14/340,961
Granted
Apr 2, 2019
Kind
B2
Abstract

Methods, systems and apparatus are disclosed for delivery of pulsed treatment radiation by employing a pump radiation source generating picosecond pulses at a first wavelength, and a frequency-shifting resonator having a lasing medium and resonant cavity configured to receive the picosecond pulses from the pump source at the first wavelength and to emit radiation at a second wavelength in response thereto, wherein the resonant cavity of the frequency-shifting resonator has a round trip time shorter than the duration of the picosecond pulses generated by the pump radiation source. Methods, systems and apparatus are also disclosed for providing beam uniformity and a sub-harmonic resonator.

Claims (42)

1. An apparatus for delivery of pulsed treatment radiation comprising:

a pump radiation source generating picosecond pulses at a first wavelength, and

a wavelength-shifting resonator having a lasing medium and resonant cavity configured to receive the picosecond pulses from the pump radiation source at the first wavelength and to emit radiation at a second wavelength in response thereto,

wherein the resonant cavity of the wavelength-shifting resonator has a round trip time shorter than duration of the picosecond pulses generated by the pump radiation source, and the wavelength-shifting resonator operates without use of a modelocker or a Q-switch.

2. The apparatus of claim 1 , wherein the wavelength-shifting resonator has a round trip time at least 5 times shorter than the duration of the picosecond pulses generated by the pump radiation source.

3. The apparatus of claim 1 , wherein the wavelength-shifting resonator has a round trip time at least 10 times shorter than the duration of the picosecond pulses generated by the pump radiation source.

4. The apparatus of claim 1 , wherein the wavelength-shifting resonator has a cavity length less than 10 millimeters.

5. The apparatus of claim 1 , wherein the lasing medium of the wavelength-shifting resonator comprises a neodymium-doped crystal.

6. The apparatus of claim 5 , wherein the lasing medium of the wavelength-shifting resonator comprises a solid state crystal medium selected from the group consisting of neodymium-doped yttrium-aluminum garnet (Nd:YAG) crystals, neodymium-doped Perovskite (Nd:YAP or Nd:YAlO 3 ) crystals, neodymium-doped yttrium-lithium-fluoride (Nd:YAF) crystals, and neodymium-doped, vanadate (Nd:YVO 4 ) crystals.

7. The apparatus of claim 1 , further comprising a polarizer embedded within the resonant cavity of the wavelength-shifting resonator.

8. The apparatus of claim 1 , wherein the lasing medium of the wavelength-shifting resonator is a polarizing medium.

9. The apparatus of claim 1 , further comprising a frequency-doubling crystal.

10. The apparatus of claim 9 , wherein the frequency-doubling crystal comprises a second harmonic generating, nonlinear crystal material.

11. The apparatus of claim 9 , wherein the frequency-doubling crystal comprises one of a lithium triborate (LiB 3 O 5 ) material or a KTP material.

12. The apparatus of claim 1 , wherein the pump radiation source is a mode-locked laser.

13. The apparatus of claim 12 , wherein the mode-locked laser comprises an alexandrite laser.

14. The apparatus of claim 12 , wherein the mode-locked laser generates pulsed laser energy having at least about 100 mJ/pulse.

15. The apparatus of claim 12 , wherein the mode-locked laser generates pulsed laser energy has a pulse duration of less than 1000 picoseconds.

16. The apparatus of claim 1 , further comprising a treatment beam delivery system configured to apply a treatment beam to a patient's skin.

17. The apparatus of claim 16 , wherein the treatment beam comprises at least one of picosecond pulses from the pump radiation source at the first wavelength, picosecond pulses emitted by the wavelength-shifting resonator at the second wavelength, and picosecond pulses at a third wavelength, wherein the picosecond pulses at the third wavelength are output by a frequency-doubling crystal that receives the picosecond pulses at the second wavelength.

18. The apparatus of claim 17 , wherein the first wavelength is about 755 nm, the second wavelength is about 1064 nm, and the third wavelength is about 532 nm.

19. A method for shifting wavelength of a picosecond optical radiation pulse, the method comprising:

generating a pulse of optical radiation at a first wavelength and having a duration less than 1000 picoseconds,

pumping a wavelength-shifting resonator, operating without use of a modelocker or a Q-switch, with the pulse of optical radiation at the first wavelength, the wavelength-shifting resonator comprising a laser crystal with a high absorption coefficient at the first wavelength,

wherein a round trip time of the wavelength-shifting resonator is shorter than pumping laser pulse duration; and

extracting a pulse of radiation at a second wavelength emitted by the wavelength-shifting resonator, wherein the pulse at the second wavelength also has a duration of less than 1000 picoseconds.

20. The method of claim 19 , wherein the wavelength-shifting resonator has a round trip time at least 5 times shorter than the duration of the pumping pulse.

21. The method of claim 19 , wherein the wavelength-shifting resonator has a round trip time at least 10 times shorter than the duration of the pumping pulse.

22. The method of claim 19 , wherein the wavelength-shifting resonator has a cavity length less than 10 millimeters.

23. The method of claim 19 , wherein the laser crystal comprises a neodymium-doped crystal.

24. The method of claim 23 , wherein the laser crystal comprises a solid state crystal medium selected from the group comprising neodymium-doped yttrium-aluminum garnet (Nd:YAG) crystals, neodymium-doped pervoskite (Nd:YAP or Nd:YAlO 3 ) crystals, neodymium-doped yttrium-lithium-fluoride (Nd:YAF) crystals, and neodymium-doped vanadate (Nd:YVO 4 ) crystals.

25. The method of claim 19 , further comprising transmitting the pulse of radiation at a second wavelength through a frequency doubling crystal.

26. A method for treating tattoos or skin pigmentation disorders using a picosecond optical radiation source, the method comprising:

employing a pump radiation source to generate a pulse of optical radiation at a first wavelength, wherein the pulse has a duration of less than 1000 picoseconds,

pumping a wavelength-shifting resonator, operating without use of a modelocker or a Q-switch, with the pulse of optical radiation at the first wavelength, the wavelength-shifting resonator comprising a laser crystal with high absorption coefficient at the first wavelength,

wherein a round trip time of the wavelength-shifting resonator is shorter than the pumping laser pulse duration;

extracting a pulse of radiation at a second wavelength emitted by the wavelength-shifting resonator, wherein the pulse at the second wavelength also has a duration of less than 1000 picoseconds;

delivering the pulse of radiation at the second wavelength to a frequency-doubling crystal so as to generate a pulse of radiation at a third wavelength, wherein the pulse at the third wavelength also has a duration of less than 1000 picoseconds; and

directing the pulse at the third wavelength to a tattoo pigment or a skin pigmentation target to disrupt the target and promote clearance thereof.

27. The apparatus of claim 1 , further comprising controlling a temperature of the wavelength-shifting resonator.

28. The method of claim 19 wherein the duration of each pulse is greater than 1 picosecond.

29. The method of claim 26 wherein the duration of each pulse is greater than 1 picosecond.

Assignments (10)
PARTIAL RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 042261/0911 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: CYNOSURE, LLC, AS SUCCESSOR-BY-CONVERSION TO CYNOSURE, INC.
Reel/Frame 075456/0791 →
RELEASE OF SECURITY INTEREST Recorded Mar 1, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 066723/0227 →
TERMINATION AND RELEASE OF PATENTS Recorded Feb 29, 2024
From: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
To: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 066707/0957 →
ABL NOTICE AND CONFIRMATION OF GRANT OFSECURITY INTEREST IN PATENTS Recorded Jan 12, 2024
From: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 066222/0937 →
NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jan 7, 2020
From: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 051496/0579 →
RELEASE OF SECURITY INTEREST IN PATENT RIGHTS Recorded Dec 30, 2019
From: BANK OF AMERICA, N.A.
To: CYNOSURE, LLC
Reel/Frame 051447/0536 →
SECURITY INTEREST Recorded Oct 14, 2019
From: HOLOGIC, INC.; CYNOSURE, LLC; CYTYC CORPORATION; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 050719/0701 →
CHANGE OF NAME Recorded Mar 22, 2019
From: CYNOSURE, INC.
To: CYNOSURE, LLC
Reel/Frame 048678/0928 →
SECURITY INTEREST Recorded May 3, 2017
From: CYNOSURE, INC.; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 042261/0911 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2017
From: SIERRA, RAFAEL ARMANDO; MIRKOV, MIRKO GEORGIEV
To: CYNOSURE, INC.
Reel/Frame 041728/0585 →
Continuity (4)
Continuation 14216353 · Mar 17, 2014
Provisional Application 61789144 · Mar 15, 2013
Provisional Application 61891299 · Oct 15, 2013
Related Publication 20140371730A1 · Dec 18, 2014
Cited By (3)
US 12,193,734 US 12,376,904 US 12,514,456